发明授权
US07265107B2 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
有权
对抗耐药微生物有效的利福霉素C-11肟环衍生物
- 专利标题： Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
- 专利标题（中）： 对抗耐药微生物有效的利福霉素C-11肟环衍生物
-
申请号： US11076173申请日： 2005-03-09
-
公开(公告)号： US07265107B2公开(公告)日： 2007-09-04
- 发明人: Jing Li , Zhenkun Ma
- 申请人： Jing Li , Zhenkun Ma
- 申请人地址： US TX Dallas
- 专利权人： Cumbre Pharmaceuticals Inc.
- 当前专利权人： Cumbre Pharmaceuticals Inc.
- 当前专利权人地址： US TX Dallas
- 代理机构： Jackson Walker L.L.P.
- 主分类号： C07D498/18
- IPC分类号： C07D498/18 ; A61K31/395 ; A61K31/535 ; A61P31/04
摘要：
The current invention relates to a series of rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms, specifically, the 3,4-cyclo-rifamycin derivatives having an oxime group at the C-11 position.